FCHS Stock UPDATES First Choice Healthcare Solutions (FCHS) 0.8096

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Choice Healthcare Solutions (FCHS) 0.8096 $FCHS

First Choice Healthcare Reports Record Revenue and Second Quarter 2014 Results
Marketwire - Thu Aug 14, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice" , a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced its second quarter financial results for the three and six months ended June 30, 2014.

First Choice Healthcare to Present at FSXinterlinked Investment Conference
Marketwire - Fri Jul 25, 6:00AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice" , a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, announced today its presentation at the upcoming FSX Investment Conference, to be held at the Four Seasons Westlake Village, California, from July 30 to August 2, 2014.

First Choice Healthcare Solutions Announces Record 2013 Year-End Results
Marketwire - Tue Apr 01, 7:32AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice" , a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced its financial results for the fiscal year ended December 31, 2013.

First Choice Healthcare Solutions Announces Preliminary Fourth Quarter and Full Year 2013 Unaudited Revenue Results
Marketwire - Thu Jan 16, 2:15PM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" , a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced preliminary unaudited revenues for the three months and full year ended December 31, 2013.

First Choice Healthcare to Present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference
Marketwire - Wed Jan 15, 12:57PM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" , a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced that the Company is scheduled to present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference to be held January 19-22, 2014 at Club Med's Sandpiper Bay Resort & Spa in Port Saint Lucie, Florida. The Company's management team will also be available for one-on-one meetings with Conference attendees.

First Choice Healthcare Solutions, Inc. Subsidiary Secures $1.5 Million A/R Line of Credit
Marketwire - Fri Jun 28, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (OTCBB: FCHS) announced today that its subsidiary, First Choice Medical Group, ("FCMG" has secured a $1.5 million A/R line of credit from CT Capital, Ltd. d/b/a CT Capital, LP.

First Choice Healthcare Solutions, Inc. Reports 2013 First Quarter Earnings
Marketwire - Fri May 17, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (OTCBB: FCHS) announced today the 2013 first quarter financial and operational results.

/ CORRECTION - First Choice Healthcare Solutions, Inc. Reports Positive EBIDTA in Opening Year of Operations
Marketwire - Thu Apr 04, 1:30PM CDT
In the news release, "First Choice Healthcare Solutions, Inc. Reports Positive EBIDTA in Opening Year of Operations," issued earlier today by First Choice Healthcare Solutions (OTCQB: FCHS) (OTCBB: FCHS), we are advised by the company that the quoted text in the fifth paragraph should begin "With the first quarter of 2013 already completed, we are confident the Company will report an outstanding $1.4MM in gross revenues for Q1 2013, well outperforming Q1 2012 gross revenues of $330,000, with a confident $275,000 of positive EBIDTA for Q1 2013. The Center of Excellence was operating only at 6% of its attainable capacity at year-end 2012 since it was just launched last year." rather than "With the first quarter of 2013 already completed, we are confident the Company will report an outstanding $275,000 or more in first quarter revenue plus positive EBIDTA. The Center of Excellence was operating only at 6% of its capacity by the end of 2012 since it was just launched last year." as originally issued. Complete c

First Choice Healthcare Solutions, Inc. Reports Positive EBIDTA in Opening Year of Operations
Marketwire - Thu Apr 04, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (OTCBB: FCHS) today reported solid progress in its 2012 year-end results.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 26

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 68

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 9

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 39

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 35

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 182

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Texas Restaurants Get a New Read on Customer Demand

Updated Category News Views 148

Texas restaurant owners are being handed a sharper flashlight, and frankly it is overdue. HundredX and the Texas Restaurant Association have launched a pilot that gives TRA members access to the HundredX Restaurant Insights Platform, aiming to bring customer and market intelligence to the independent operators and regional chains that usually cannot pay big-company prices...

Continue Reading
Knowles Expands Its Teacher Pipeline With 39 Fellows

Updated Category News Views 32

Thirty-Nine Teachers Is Not a Trivial Signal Thirty-nine new math and science teachers may not rattle public markets, but it says plenty about where the real strain sits in American education. The Knowles Teacher Initiative has named its 2026 Teaching Fellowship class, its largest ever, and the timing is dead serious: schools are still wrestling with recruiting and...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation into GoHealth, Inc. Sparks Investor Concerns

Updated Category News Views 354

GoHealth, Inc. Under Investigation for Alleged Securities Fraud Pomerantz LLP has initiated an investigation regarding potential claims involving investors of GoHealth, Inc. (NASDAQ: GOCO). This probe aims to determine whether the company and some of its executives have participated in misleading practices concerning their financial statements. The firm is reaching out to...

Continue Reading
Exploring the Features of the 2026 Toyota GR Corolla

Updated Category News Views 334

Unleashing the Adventure with the 2026 Toyota GR Corolla Get ready for an adventurous experience with the all-new 2026 Toyota GR Corolla. Engineered to perfection, this vehicle is equipped with the innovative GR-FOUR All-Wheel Drive System, making it a formidable companion whether you're racing on the track or maneuvering through rugged terrains. The GR Corolla is...

Continue Reading
Tandem Diabetes Care Boosts Sales Guidance After Q3 Success

Updated Category News Views 65

Tandem Diabetes Care Reports Impressive Q3 Financial Results Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading name in insulin delivery and diabetes management technology, has reported its financial accomplishments for the third quarter of 2024. Following an exceptional performance, the company has also increased its sales guidance for the upcoming fiscal year. Key...

Continue Reading
Green IT Services Growth: A Comprehensive Market Overview

Updated Category News Views 193

Green IT Services Market: A Dynamic Overview The evolution of technology is more than just a trend; it represents a paradigm shift towards sustainability. As organizations embrace digital transformation, the focus on Green IT services has rapidly gained importance. The latest analyses indicate that the Green IT Services market, valued at USD 18.8 billion in recent years,...

Continue Reading
Duke Energy's Response to Hurricane Helene's Aftermath

Updated Category News Views 558

Hurricane Helene Aftermath and Power Restoration Efforts Following the severe impact of Hurricane Helene, Duke Energy (NYSE: DUK) has made remarkable progress in restoring electrical services to over 2.16 million customers. Despite these extensive restoration efforts, around 334,000 customers are still without power, largely in Upstate South Carolina and the mountainous...

Continue Reading